These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 2507953
1. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Seifert V, Eisert WG, Stolke D, Goetz C. Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953 [Abstract] [Full Text] [Related]
2. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Hariton GB, Findlay JM, Weir BK, Kasuya H, Grace MG, Mielke BW. Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810 [Abstract] [Full Text] [Related]
3. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Stolke D, Seifert V. Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590 [Abstract] [Full Text] [Related]
4. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM. J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259 [Abstract] [Full Text] [Related]
5. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Steinberg GK, Vanefsky MA, Marks MP, Adler JR, Koenig GH. Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377 [Abstract] [Full Text] [Related]
6. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data. Seifert V. Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533 [Abstract] [Full Text] [Related]
7. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Findlay JM, Weir BK, Kanamaru K, Grace M, Baughman R. Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630 [Abstract] [Full Text] [Related]
9. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB. J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534 [Abstract] [Full Text] [Related]
10. The effect of tissue plasminogen activator (t-PA) on cerebral vasospasm in canine subarachnoid hemorrhage. Chung WY, Lee LS. Zhonghua Yi Xue Za Zhi (Taipei); 1993 Nov; 52(5):298-306. PubMed ID: 8299025 [Abstract] [Full Text] [Related]
11. Effect of tissue plasminogen activator on intimal platelet accumulation in cerebral arteries after subarachnoid hemorrhage in cats. Yamamoto Y, Clower BR, Haining JL, Smith RR. Stroke; 1991 Jun; 22(6):780-4. PubMed ID: 1905429 [Abstract] [Full Text] [Related]
12. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Findlay JM, Kassell NF, Weir BK, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW. Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685 [Abstract] [Full Text] [Related]
13. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Usui M, Saito N, Hoya K, Todo T. Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383 [Abstract] [Full Text] [Related]
14. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T. J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145 [Abstract] [Full Text] [Related]
15. Intraoperative use of rtPA for subarachnoid hemorrhage. Schmidt JH, Christenson JT. W V Med J; 1994 Mar; 90(3):98-100. PubMed ID: 8197745 [Abstract] [Full Text] [Related]
16. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Kim CJ, Bassiouny M, Macdonald RL, Weir B, Johns LM. Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140 [Abstract] [Full Text] [Related]
17. Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm. Bell TE, Kongable GL. J Neurosci Nurs; 1996 Apr; 28(2):107-13. PubMed ID: 8718759 [Abstract] [Full Text] [Related]
18. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage. Yamamoto T, Esaki T, Nakao Y, Mori K. World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155 [Abstract] [Full Text] [Related]
19. Thrombolytic therapy with tissue plasminogen activator for prevention of vasospasm in experimental subarachnoid hemorrhage: its efficacy and problems. Asada M, Kong J, Nakamura M, Tamaki N. Neurol Res; 1996 Aug; 18(4):342-4. PubMed ID: 8875453 [Abstract] [Full Text] [Related]
20. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report. Mizoi K, Yoshimoto T, Fujiwara S, Sugawara T, Takahashi A, Koshu K. Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]